Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

Summary

The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The study will last about 24 weeks.

Timeline

Start

2024-10-09

Primary completion

2024-12-30

Completion

2024-12-30

Outcome

Outcome not reported

Stopped: “Study was terminated due to a lack of foreseeable clinical benefit in the proposed chronic kidney disease population, following the termination of a related heart failure study that demonstrated no benefit in an overlapping patient group.”

Drugs

Indications